Market closed
Kamada/KMDA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Kamada
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Ticker
KMDA
Sector
Trading on
Industry
Biotechnology
Headquarters
Rehovot, Israel
Employees
378
Website
Kamada Metrics
BasicAdvanced
$303M
Market cap
20.99
P/E ratio
$0.25
EPS
0.24
Beta
-
Dividend rate
Price and volume
Market cap
$303M
Beta
0.24
52-week high
$6.53
52-week low
$4.08
Average daily volume
24K
Financial strength
Current ratio
4.07
Quick ratio
2.145
Long term debt to equity
2.813
Total debt to equity
3.408
Management effectiveness
Return on assets (TTM)
3.16%
Return on equity (TTM)
7.04%
Valuation
Price to earnings (TTM)
20.987
Price to revenue (TTM)
1.85
Price to book
4.36
Price to tangible book (TTM)
9.58
Price to free cash flow (TTM)
26.193
Growth
Revenue change (TTM)
6.01%
Earnings per share change (TTM)
230.67%
3-year revenue growth (CAGR)
10.04%
3-year earnings per share growth (CAGR)
-1.42%
What the Analysts think about Kamada
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Kamada stock.
Kamada Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Kamada Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Kamada News
AllArticlesVideos
Kamada Announces Expansion of Plasma Collection Operations in Texas with the Opening of New Site in Houston
GlobeNewsWire·3 weeks ago
Kamada Ltd. (KMDA) Q2 2024 Earnings Call Transcript
Seeking Alpha·2 months ago
Kamada to Announce Second Quarter and First Half Ended June 30, 2024 Financial Results and Host Conference Call on August 14, 2024
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Kamada stock?
Kamada (KMDA) has a market cap of $303M as of October 14, 2024.
What is the P/E ratio for Kamada stock?
The price to earnings (P/E) ratio for Kamada (KMDA) stock is 20.99 as of October 14, 2024.
Does Kamada stock pay dividends?
No, Kamada (KMDA) stock does not pay dividends to its shareholders as of October 14, 2024.
When is the next Kamada dividend payment date?
Kamada (KMDA) stock does not pay dividends to its shareholders.
What is the beta indicator for Kamada?
Kamada (KMDA) has a beta rating of 0.24. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.